Sample average treatment effect on the treated analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma
View ORCID ProfileAmit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, Vithal Madhira, Timothy Bergquist, Yu Raymond Shao, Feifan Liu, Qianqian Song, Jing Su, Shaji Kumar, Benjamin A. Bates, Noha Sharafeldin, Umit Topaloglu the National COVID Cohort Collaborative Consortium
doi: https://doi.org/10.1101/2022.12.07.22283208
Amit Kumar Mitra
1Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL
2Center for Pharmacogenomics and Single-Cell Omics (AUPharmGx), Auburn University, Auburn, AL
3UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
Ujjal Kumar Mukherjee
4University of Illinois, Urbana-Champaign, IL
Suman Mazumder
1Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL
2Center for Pharmacogenomics and Single-Cell Omics (AUPharmGx), Auburn University, Auburn, AL
Vithal Madhira
5Palila Software LLC, Reno, NV
Timothy Bergquist
6Sage Bionetworks, Seattle, WA
Yu Raymond Shao
7Duke University Medical Center, NC
Feifan Liu
8University of Massachusetts Chan Medical School, MA
Qianqian Song
9Wake Forest School of Medicine Winston-Salem, NC, USA
Jing Su
10Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN
Shaji Kumar
11Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
Benjamin A. Bates
12Department of Medicine, Rutgers-RWJMS Medical School, New Brunswick, NJ
Noha Sharafeldin
13School of Medicine, University of Alabama at Birmingham, Birmingham, AL
Umit Topaloglu
9Wake Forest School of Medicine Winston-Salem, NC, USA
Posted December 08, 2022.
Sample average treatment effect on the treated analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma
Amit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, Vithal Madhira, Timothy Bergquist, Yu Raymond Shao, Feifan Liu, Qianqian Song, Jing Su, Shaji Kumar, Benjamin A. Bates, Noha Sharafeldin, Umit Topaloglu
medRxiv 2022.12.07.22283208; doi: https://doi.org/10.1101/2022.12.07.22283208
Sample average treatment effect on the treated analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma
Amit Kumar Mitra, Ujjal Kumar Mukherjee, Suman Mazumder, Vithal Madhira, Timothy Bergquist, Yu Raymond Shao, Feifan Liu, Qianqian Song, Jing Su, Shaji Kumar, Benjamin A. Bates, Noha Sharafeldin, Umit Topaloglu
medRxiv 2022.12.07.22283208; doi: https://doi.org/10.1101/2022.12.07.22283208
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (191)
- Cardiovascular Medicine (2840)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12550)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4421)
- Geriatric Medicine (401)
- Health Economics (714)
- Health Informatics (2847)
- Health Policy (1047)
- Hematology (374)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4182)
- Nursing (221)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6772)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)